EMEIS SA (EMEIS.PA) Stock Fundamental Analysis
Europe - EPA:EMEIS - FR001400NLM4 - Common Stock
14.34 EUR
+0.34 (+2.43%)
We assign a fundamental rating of 1 out of 10 to EMEIS. EMEIS was compared to 31 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of EMEIS have multiple concerns. EMEIS does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
EMEIS had negative earnings in the past year.
EMEIS had a positive operating cash flow in the past year.
In multiple years EMEIS reported negative net income over the last 5 years.
Each year in the past 5 years EMEIS had a positive operating cash flow.
1.2 Ratios
EMEIS has a Return On Assets of -3.07%. This is amonst the worse of the industry: EMEIS underperforms 90.32% of its industry peers.
With a Return On Equity value of -23.89%, EMEIS is not doing good in the industry: 90.32% of the companies in the same industry are doing better.
The Return On Invested Capital of EMEIS (0.03%) is worse than 87.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROIC | 0.03% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of EMEIS (0.08%) is worse than 87.10% of its industry peers.
EMEIS's Operating Margin has declined in the last couple of years.
EMEIS does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EMEIS is destroying value.
The number of shares outstanding for EMEIS has been increased compared to 1 year ago.
Compared to 5 years ago, EMEIS has less shares outstanding
The debt/assets ratio for EMEIS is higher compared to a year ago.
2.2 Solvency
EMEIS has an Altman-Z score of 0.63. This is a bad value and indicates that EMEIS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.63, EMEIS is doing worse than 77.42% of the companies in the same industry.
EMEIS has a debt to FCF ratio of 51.23. This is a negative value and a sign of low solvency as EMEIS would need 51.23 years to pay back of all of its debts.
With a Debt to FCF ratio value of 51.23, EMEIS is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
EMEIS has a Debt/Equity ratio of 4.80. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 4.80, EMEIS is not doing good in the industry: 87.10% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Altman-Z | 0.63 |
ROIC/WACC0.01
WACC4.78%
2.3 Liquidity
A Current Ratio of 0.62 indicates that EMEIS may have some problems paying its short term obligations.
With a Current ratio value of 0.62, EMEIS is not doing good in the industry: 83.87% of the companies in the same industry are doing better.
A Quick Ratio of 0.62 indicates that EMEIS may have some problems paying its short term obligations.
EMEIS has a Quick ratio of 0.62. This is in the lower half of the industry: EMEIS underperforms 77.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
EMEIS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -136.53%.
EMEIS shows a small growth in Revenue. In the last year, the Revenue has grown by 6.30%.
Measured over the past years, EMEIS shows a quite strong growth in Revenue. The Revenue has been growing by 8.55% on average per year.
EPS 1Y (TTM)-136.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
3.2 Future
The Earnings Per Share is expected to grow by 17.92% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.70% on average over the next years.
EPS Next Y24.08%
EPS Next 2Y24.28%
EPS Next 3Y21.78%
EPS Next 5Y17.92%
Revenue Next Year4.84%
Revenue Next 2Y4.72%
Revenue Next 3Y4.75%
Revenue Next 5Y2.7%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for EMEIS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EMEIS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EMEIS is valued expensively inside the industry as 83.87% of the companies are valued cheaper.
EMEIS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.27 | ||
| EV/EBITDA | 22.44 |
4.3 Compensation for Growth
A more expensive valuation may be justified as EMEIS's earnings are expected to grow with 21.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.28%
EPS Next 3Y21.78%
5. Dividend
5.1 Amount
No dividends for EMEIS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:EMEIS (10/24/2025, 5:29:39 PM)
14.34
+0.34 (+2.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners56.3%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap2.32B
Revenue(TTM)5.77B
Net Income(TTM)-412065000
Analysts75.38
Price Target12.34 (-13.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-98.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)-0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.41 | ||
| P/FCF | 13.27 | ||
| P/OCF | 4.9 | ||
| P/B | 1.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.44 |
EPS(TTM)-1.8
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)1.08
FCFY7.54%
OCF(TTM)2.92
OCFY20.39%
SpS34.91
BVpS10.68
TBVpS-7.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROCE | 0.04% | ||
| ROIC | 0.03% | ||
| ROICexc | 0.03% | ||
| ROICexgc | 0.04% | ||
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 3.1% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-77.23%
ROICexgc growth 5Y-61.49%
ROICexc growth 3Y-76.08%
ROICexc growth 5Y-60.94%
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Debt/EBITDA | 17.9 | ||
| Cap/Depr | 64.95% | ||
| Cap/Sales | 5.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.08% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 0.63 |
F-Score4
WACC4.78%
ROIC/WACC0.01
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)5.82%
Cap/Sales(5y)13.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
EPS Next Y24.08%
EPS Next 2Y24.28%
EPS Next 3Y21.78%
EPS Next 5Y17.92%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
Revenue Next Year4.84%
Revenue Next 2Y4.72%
Revenue Next 3Y4.75%
Revenue Next 5Y2.7%
EBIT growth 1Y103.51%
EBIT growth 3Y-77.35%
EBIT growth 5Y-61.53%
EBIT Next Year10732.9%
EBIT Next 3Y416.71%
EBIT Next 5Y253.09%
FCF growth 1Y293.3%
FCF growth 3YN/A
FCF growth 5Y14.58%
OCF growth 1Y28.92%
OCF growth 3Y-14.44%
OCF growth 5Y-10.16%
EMEIS SA / EMEIS.PA FAQ
What is the ChartMill fundamental rating of EMEIS SA (EMEIS.PA) stock?
ChartMill assigns a fundamental rating of 1 / 10 to EMEIS.PA.
What is the valuation status for EMEIS stock?
ChartMill assigns a valuation rating of 2 / 10 to EMEIS SA (EMEIS.PA). This can be considered as Overvalued.
What is the profitability of EMEIS stock?
EMEIS SA (EMEIS.PA) has a profitability rating of 1 / 10.
Can you provide the financial health for EMEIS stock?
The financial health rating of EMEIS SA (EMEIS.PA) is 0 / 10.
Can you provide the dividend sustainability for EMEIS stock?
The dividend rating of EMEIS SA (EMEIS.PA) is 0 / 10 and the dividend payout ratio is 0%.